As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
The call for papers for our upcoming special issue on ‘Targeting cancer evolution in the clinic’, guest edited by Razelle Kurzrock and Alberto Bardelli is now open.
Janine LaSalle and colleagues study the cord blood methylome in a high-familial risk cohort of autism spectrum disorder and identify a methylation signature at birth.
Our special issue on ‘Translating the microbiome in health and disease’, guest edited by Ramnik Xavier has launched. Check out new content added over the next months.
Daniel Koboldt discusses current best practices for variant calling in clinical sequencing studies, focusing on inherited disorders and cancer somatic mutation detection.
Reviews, Research Highlights and Commentaries
Focus: Immunology in Health and Disease
Read the latest papers on immunology across BMC flagship journals.
Association between the cytokine storm, immune cell dynamics, and viral replicative capacity in hyperacute HIV infection
Daniel M. Muema et al.
Published in BMC Medicine 25 March 2020
The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology
Shashuang Zhang et al.
Published in BMC Biology 17 March 2020
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma
Markus W. Löffler et al.
Published in Genome Medicine 30 April 2019
Host-associated microbiomes are predicted by immune system complexity and climate
Douglas C. Woodhams et al.
Published in Genome Biology 03 February 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
A decade of Genome Medicine
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
From the blog
12 November 2020
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
C19 Rapid Review initiative
Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here.
Submissions from medRxiv
Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.